Product Information
PSEUDOEPHEDRINE 30 MG TABLET is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.0776 per EA under NDC 45802043262. Its NADAC has been published 671 times since Nov 28, 2013.
Strength
30 mg/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802043262
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
10/17/2008
Pharmacological Classes
Price Statistics
The NADAC for PSEUDOEPHEDRINE 30 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 89.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0776 per EA |
|---|---|
| All-time high | $0.0780 (Sep 16, 2026) |
| All-time low | $0.0409 (Nov 28, 2013) |
| 52-week high | $0.0780 |
| 52-week low | $0.0598 |
| Median price | $0.0507 |
| Average price | $0.0524 |
| Largest weekly change | +33.4% (Nov 22, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pseudoephedrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PSEUDOEPHEDRINE 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PSEUDOEPHEDRINE 30 MG TABLET, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.0776 per EA (NDC 45802043262), effective Sep 30, 2026.
How has the price of PSEUDOEPHEDRINE 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PSEUDOEPHEDRINE 30 MG TABLET has risen 89.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PSEUDOEPHEDRINE 30 MG TABLET?
Since Nov 28, 2013, the NADAC for PSEUDOEPHEDRINE 30 MG TABLET has ranged from a low of $0.0409 (Nov 28, 2013) to a high of $0.0780 (Sep 16, 2026), with a median of $0.0507 per EA.
Are there cheaper alternatives to PSEUDOEPHEDRINE 30 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NASAL DECONGESTANT 30 MG TAB, is $0.0539 per EA — about 30% below PSEUDOEPHEDRINE 30 MG TABLET.
Who manufactures PSEUDOEPHEDRINE 30 MG TABLET?
PSEUDOEPHEDRINE 30 MG TABLET (NDC 45802043262) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.